Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Cytomegalovirus infection is affecting patients post COVID-19

IgA-virus Immune Complex: Neutrophil’s trap for SARS-CoV-2

“Death Star” in cancer biology- the mutated form of RAS protein

Cytomegalovirus infection is affecting patients post COVID-19
  • BiotechToday
  • World

Cytomegalovirus infection is affecting patients post COVID-19

bioxone July 3, 2021July 3, 2021

Husna, Amity University Kolkata

Cytomegalovirus (CMV), affecting COVID-19 patients who are immunocompromised, has been detected. During the second wave of the pandemic in April-May, five cases of CMV infection in immunocompromised patients with Covid-19 were reported in Sir Ganga Ram Hospital, New Delhi. The hospital reported that the patients presented themselves with pain in the abdomen, blood in stools, or intestinal obstruction around 20-30 days after their COVID-19 diagnosis. Out of the 5 cases, one person even succumbed to death due to massive bleeding and four patients had lower gastrointestinal bleeding, and three of them recovered. Seven cases were detected in Mumbai as well, where the COVID recovered patients returned to the hospital with the symptoms of CMV pneumonia such as inflammation and fluid build-up in the lungs.

What is Cytomegalovirus (CMV)?

 It is a double-stranded DNA virus and a member of the Human Herpesvirus family. It is related to the Herpes virus that causes cold sore or chickenpox, according to the National Health Service (NHS), UK.

Cytomegalovirus infections (CMV) are detected in post-transplant patients or in patients who have weakened immune systems caused by cancer or AIDS. So, doctors believe that COVID-19 patients who have compromised immunity may be more prone to develop this virus. The patients who had severe COVID-19 were treated with steroid therapy, which even makes their immune system more susceptible to some uncommon infections.

Associated symptoms of CMV

Cytomegalovirus primarily affects people with weakened immunity. There are a few signs and symptoms which can be observed in those who have contracted the virus. Severe symptoms are diarrhoea, abdominal pain, fever, rectal bleeding, and weight loss.

As per CDC, Sore throat, muscle aches, fatigue, swollen glands, skin rash, and fever might be some of the most common symptoms. These symptoms can even disappear without treatment in three weeks, only for those with a healthy immune system.

 How can CMV be diagnosed?

Doctors recommend blood and urine tests which include CMV antigen, a virus culture, or PCR, to diagnose the virus.

Treatment of CMV: 

CMV is a transmissible disease and spreads to others when they come in contact with someone who has the disease. This can be via sexual contact or bodily fluids, such as urine, blood, saliva, tears, and faeces. The virus has no permanent treatment. Although antiviral medication can suppress the virus, it will not fully take it out of the system. If someone contracts CMV then it stays with them throughout their lifetime.

Also read: IgA-virus Immune Complex: Neutrophil’s trap for SARS-CoV-2

Sources: 

  1. “Coronavirus: What Is Cytomegalovirus? How Is It Affecting COVID-19 Patients?” The Times of India, 1 July 2021, https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/coronavirus-what-is-cytomegalovirus-how-is-it-affecting-covid-19-patients/photostory/84014261.cms.
  2. “Everything You Need to Know about Cytomegalovirus Affecting Those Who Recovered from Covid-19.” Deccan Herald, 1 July 2021, https://www.deccanherald.com/science-and-environment/everything-you-need-to-know-about-cytomegalovirus-affecting-those-who-recovered-from-covid-19-1003621.html.
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

About the Author: Husna is an undergraduate student of BTech Biotechnology at Amity University Kolkata. She is a research enthusiast in Immunology and Immunotherapy but she has a keen interest in various other bioscience subjects as well. She is constantly focused on improving her knowledge and laboratory skills through various internships. She is a Scientific content writer who has knowledge in diverse backgrounds of Biotechnology.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged covid 19 cases covid 19 diarrhoea symptoms nhs covid 19 patient precautions covid-19 india cytomegalovirus and covid cytomegalovirus and herpes simplex virus cytomegalovirus and std cytomegalovirus cure cytomegalovirus diagnosis test cytomegalovirus infection cytomegalovirus symptoms immunocompromised after covid immunocompromised and covid immunocompromised diseases immunocompromised patients post covid-19 diarrhoea

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

“Death Star” in cancer biology- the mutated form of RAS protein

BioTech Today July 3, 2021

Sayak Banerjee, Amity University Kolkata The scientists at the University of Leeds have discovered a new method of targeting a mutated protein, which is the reason behind most of the fatal cancers. The mutated form of RAS protein is often considered the “Death Star” since it has the potential to resist various treatments. Although RAS […]

Related Post

  • BiotechToday
  • World

LED Lighting Improves Microalgae for Next-Generation Biofuel !!!

bioxone April 21, 2021April 21, 2021

Sagnik Nag , Amity University Kolkata As ethanol, biodiesel, and other biofuels being conventional fuel sources, continue to pose challenges, such as stringent competition with food security or lack of adequate technology for more efficient and low-cost production, microalgae are now gaining momentum as a biofuel energy crop.  According to the current scientific research work, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

STEROIDS AS A MONUMENTAL REMEDY TO PRE-TERM BIRTH PITFALLS

bioxone October 28, 2020October 28, 2020

Arpan Banerjee, University of Calcutta Prematurity or pre-term birth has become one of the most alarming cases about child mortality all across the globe. Approximately, 1.1 million pre-term babies perish every year throughout the world. By definition, it is the birth of a baby at lesser than 37 weeks, as opposed to the usual which […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India

Variation of SARS-CoV-2 genomes in populations due to RNA editing enzymes

bioxone December 14, 2020December 14, 2020

Prama Ghosh, Amity University Kolkata The SARS-CoV-2 virus has infected millions around the globe since its transmission in the human host. Extensive diversification of the virus including significant molecular differences has resulted in failure to diagnose the virus. The virus undergoes continuous evolution and adaptation inside the body of the host, which helps it to survive […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy